// App-Quantinova.ai

18594 : Efficacy of Dabigatran versus Warfarin in Patients With Acute Venous Thromboembolism and Thrombophilia: A Pooled Analysis of RE-COVER and RE-COVER II

Researchers

Presenter

  • Sam Schulman

Principal Investigators

  • Henry Eriksson

  • Samuel Z Goldhaber

  • Ajay Kakkar

  • Clive Kearon

  • Patrick Mismetti

  • Martin Feuring

  • Stefan Hantel

  • Joerg Kreuzer

  • Sebastian Schellong

Medical Centers

  • Brigham & Women's Hospital, Boston, MA

  • Sahlgrenska University Hospital, Gothenburg, Sweden

  • McMaster University, Hamilton, ON, Canada

  • Municipal Hospital Friedrichstadt, Dresden, Germany

  • Thrombosis Research Institute, London, United Kingdom

  • Bellevue Hosp, St Etienne, France

Locations

  • Canada

  • Germany

  • United Kingdom

  • United States

  • France

  • Sweden

Companies

  • Boehringer Ingelheim

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Venous thrombosis

  • Deep vein thrombosis

  • Pulmonary embolism

Biomarkers

  • N/A

Drug/Treatment

  • Pradax

  • Hydroxyzine

  • Warfarin

Outcome

  • N/A

Study Design

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved